Antihyperlipidemic Drugs Market Driven by Rising Prevalence of Cardiovascular Diseases
The Antihyperlipidemic Drugs Market is witnessing steady expansion as the global prevalence of hyperlipidemia and cardiovascular disorders continues to rise. Increasing awareness of cholesterol management, growing healthcare expenditure, and broader access to advanced lipid-lowering therapies are supporting market growth across developed and emerging economies. Pharmaceutical innovation,...
0 Comments 0 Shares 203 Views 0 Reviews